TFA Therapeutics RAJAF
OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

TFA Therapeutics (RAJAF) Income from Non-Controlling Interests (2022 - 2023)

Updated

TFA Therapeutics' Income from Non-Controlling Interests came in at $1 million for Q4 2023, compared with -$61,579 a year earlier.

Analysis

TFA Therapeutics (RAJAF) Income from Non-Controlling Interests (2022 - 2023) Analysis & Trends

For FY2023, TFA Therapeutics' Income from Non-Controlling Interests was $872,603.

  • Going back by year, Income from Non-Controlling Interests was -$675,521 in FY2022 and -$495,401 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Procter & Gamble 336.76 Bn 292.75 Bn 10.28 Bn 38.00 Mn
2 Colgate Palmolive 67.18 Bn 62.24 Bn 3.30 Bn 26.00 Mn
3 Estee Lauder Companies 33.32 Bn 21.40 Bn 2.74 Bn -
4 Kenvue 33.09 Bn 28.70 Bn 2.30 Bn -
5 Kimberly Clark 31.38 Bn 28.71 Bn 1.60 Bn 5.00 Mn
6 Church & Dwight 22.37 Bn 20.90 Bn 693.90 Mn -
7 Clorox 9.72 Bn 8.16 Bn 804.00 Mn 4.00 Mn
8 e.l.f. Beauty 6.17 Bn 5.15 Bn 398.84 Mn -
9 Reynolds Consumer Products 4.71 Bn 4.37 Bn 245.00 Mn -
10 TFA Therapeutics 1.02 Bn 1.02 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 1.00 Mn
Dec 31, 2022 -61,579.00
API Access

TFA Therapeutics Income from Non-Controlling Interests API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=RAJAF&period=max&api_key=YOUR_API_KEY